Tom Haber

Tom Haber has a diverse work experience spanning from 1999 to present. Tom currently holds the position of Associate Director of Project Management at Hummingbird Bioscience. Previously, they worked at Immatics Biotechnologies as a Senior Program Lead from 2019 to 2021. Prior to that, they served as a Consultant at Midzise Rare Disease Biotech Company and conducted primary and secondary market research on digital health in clinical trials. Tom also worked as a Graduate Consultant at Analytik Jena AG, where they conducted market analysis and presented recommendations to executive management. Tom has a strong background in research, having worked as a Postdoctoral Research Fellow at City of Hope, where they developed nano-sized delivery systems for cancer diagnosis and therapy. Tom also holds a Ph.D. from Technion - Israel Institute of Technology, where they led the development of an ultrasound-based gene delivery system to stem cells and served as a Graduate Student Instructor. Tom's early career includes a leadership role as a Team Leader and Project Manager at IDF-Basmach-Mamram, where they managed a team and developed project plans.

Tom Haber has a diverse education history. In 2021, they completed a program in Drug and Medical Device Development at the Massachusetts Institute of Technology. Prior to that, from 2018 to 2019, they pursued a Master of Business Management with a focus on Bioscience Management at Keck Graduate Institute. Tom'sacademic journey began in 2008 when they enrolled at the Technion - Israel Institute of Technology, where they received a Doctor of Philosophy (Ph.D.) in Biotechnology, Gene & Drug Delivery in 2014. In addition to their formal education, Tom holds additional certifications in areas such as Drug and Medical Device Development and Microsoft Project.